These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25270354)

  • 1. Preclinical evaluation of recombinant T cell receptor ligand RTL1000 as a therapeutic agent in ischemic stroke.
    Zhu W; Casper A; Libal NL; Murphy SJ; Bodhankar S; Offner H; Alkayed NJ
    Transl Stroke Res; 2015 Feb; 6(1):60-8. PubMed ID: 25270354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant T-cell receptor ligand RTL1000 limits inflammation and decreases infarct size after experimental ischemic stroke in middle-aged mice.
    Zhu W; Dotson AL; Libal NL; Lapato AS; Bodhankar S; Offner H; Alkayed NJ
    Neuroscience; 2015 Mar; 288():112-9. PubMed ID: 25556831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant T cell receptor ligand treatment improves neurological outcome in the presence of tissue plasminogen activator in experimental ischemic stroke.
    Zhu W; Libal NL; Casper A; Bodhankar S; Offner H; Alkayed NJ
    Transl Stroke Res; 2014 Oct; 5(5):612-7. PubMed ID: 24953050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel humanized recombinant T cell receptor ligands protect the female brain after experimental stroke.
    Pan J; Palmateer J; Schallert T; Hart M; Pandya A; Vandenbark AA; Offner H; Hurn PD
    Transl Stroke Res; 2014 Oct; 5(5):577-85. PubMed ID: 24838614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant T cell receptor ligand treats experimental stroke.
    Subramanian S; Zhang B; Kosaka Y; Burrows GG; Grafe MR; Vandenbark AA; Hurn PD; Offner H
    Stroke; 2009 Jul; 40(7):2539-45. PubMed ID: 19443805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window.
    Belayev L; Liu Y; Zhao W; Busto R; Ginsberg MD
    Stroke; 2001 Feb; 32(2):553-60. PubMed ID: 11157196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant T cell receptor ligands improve outcome after experimental cerebral ischemia.
    Akiyoshi K; Dziennis S; Palmateer J; Ren X; Vandenbark AA; Offner H; Herson PS; Hurn PD
    Transl Stroke Res; 2011 Sep; 2(3):404-10. PubMed ID: 21961027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombin gamma attenuates macrophage/microglial activation and brain damage after transient focal cerebral ischemia in mice.
    Nakano T; Nakamura Y; Irie K; Okano S; Morimoto M; Yamashita Y; Kozako T; Hayashi T; Honda SI; Matsuo K; Kamimura H; Ishikura H; Egawa T; Mishima K
    Life Sci; 2020 Jul; 252():117665. PubMed ID: 32305521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propofol protects against focal cerebral ischemia via inhibition of microglia-mediated proinflammatory cytokines in a rat model of experimental stroke.
    Zhou R; Yang Z; Tang X; Tan Y; Wu X; Liu F
    PLoS One; 2013; 8(12):e82729. PubMed ID: 24349350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postischemic administration of basic fibroblast growth factor improves sensorimotor function and reduces infarct size following permanent focal cerebral ischemia in the rat.
    Li Q; Stephenson D
    Exp Neurol; 2002 Oct; 177(2):531-7. PubMed ID: 12429198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.
    Abdelkarim GE; Gertz K; Harms C; Katchanov J; Dirnagl U; Szabó C; Endres M
    Int J Mol Med; 2001 Mar; 7(3):255-60. PubMed ID: 11179503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between early and delayed systemic treatment with candesartan of rats after ischaemic stroke.
    Brdon J; Kaiser S; Hagemann F; Zhao Y; Culman J; Gohlke P
    J Hypertens; 2007 Jan; 25(1):187-96. PubMed ID: 17143191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabidiol reduces brain damage and improves functional recovery in a neonatal rat model of arterial ischemic stroke.
    Ceprián M; Jiménez-Sánchez L; Vargas C; Barata L; Hind W; Martínez-Orgado J
    Neuropharmacology; 2017 Apr; 116():151-159. PubMed ID: 28012949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator.
    Shimada Y; Shimura H; Tanaka R; Yamashiro K; Koike M; Uchiyama Y; Urabe T; Hattori N
    PLoS One; 2018; 13(5):e0198039. PubMed ID: 29795667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated protein C analog promotes neurogenesis and improves neurological outcome after focal ischemic stroke in mice via protease activated receptor 1.
    Wang Y; Zhao Z; Chow N; Ali T; Griffin JH; Zlokovic BV
    Brain Res; 2013 Apr; 1507():97-104. PubMed ID: 23438513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose estrogen treatment at reperfusion reduces lesion volume and accelerates recovery of sensorimotor function after experimental ischemic stroke.
    Carpenter RS; Iwuchukwu I; Hinkson CL; Reitz S; Lee W; Kukino A; Zhang A; Pike MM; Ardelt AA
    Brain Res; 2016 May; 1639():200-13. PubMed ID: 26995494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice.
    Yu GL; Wei EQ; Zhang SH; Xu HM; Chu LS; Zhang WP; Zhang Q; Chen Z; Mei RH; Zhao MH
    Pharmacology; 2005 Jan; 73(1):31-40. PubMed ID: 15452361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemia.
    Wang Y; Zhang ZG; Rhodes K; Renzi M; Zhang RL; Kapke A; Lu M; Pool C; Heavner G; Chopp M
    Br J Pharmacol; 2007 Aug; 151(8):1377-84. PubMed ID: 17603558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracerebroventricular Delivery of Recombinant NAMPT Deters Inflammation and Protects Against Cerebral Ischemia.
    Chen F; Weng Z; Xia Q; Cao C; Leak RK; Han L; Xiao J; Graham SH; Cao G
    Transl Stroke Res; 2019 Dec; 10(6):719-728. PubMed ID: 30820847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.